In the news

Dr. Brian Dunkin, chief medical officer, Endoscopy, and Mike Jones, SVP and president, Endoscopy, discuss how endoluminal surgery (ELS) products from the recent Apollo Endosurgery acquisition represent a step forward in gastrointestinal (GI) care.

If you’re looking to advance your career, Mary Beth Moynihan, senior vice president of market access and chief marketing officer, has three words for you: “You’re worth it.”

Boston Scientific’s market capitalization has grown nearly 10 times larger since Mike Mahoney joined as CEO in 2011. He shared key insights about corporate strategy at DeviceTalks Boston in May.

Eric Thépaut, executive vice president and president, Europe, Middle East and Africa, shares how digital education platforms, real-time and on-demand technologies and remote case support are being utilized to help patients.

Data supporting use of key Boston Scientific electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX™ Left Atrial Appendage Closure Device were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society.

Camille Chang Gilmore, vice president, human resources, and global chief diversity, equity & inclusion officer, shares what she believes are the core elements in a successful DEI initiative and why creating a workplace that encourages empathetic, collaborative engagement is critical for the innovation that powers the medical device industry.

Boston Scientific’s new global chief medical officer is already well-known in cardiovascular device space circles. Dr. Ken Stein joined Boston Scientific in 2009 as SVP and chief medical officer of its Rhythm Management business. He became chief medical officer for the entire company on Feb. 13.

Clinical trials are an early step in device and therapy development which have significant impact on the types of products available to patients. Boston Scientific leaders share how the company is working to advance diversity in medical research.

Trevor Boylston had transitioned from female to male a decade before he started working at Boston Scientific. He shares reflections on how navigating the world of work can be enormously challenging for members of the transgender community and how he got involved in the company’s LGBTQ resource group.

Boston Scientific introduced the first U.S. Food and Drug Administration (FDA)-cleared single-use duodenoscope in 2019. Therefore, it is fitting that our first conversation in the Industry Perspective section of iGIE is with Michael Jones, senior vice president and president, Endoscopy for Boston Scientific.